• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    NYSE Content Advisory: Pre-Market update + S&P 500 trades within 1% of record

    6/25/25 8:55:00 AM ET
    $GKOS
    $ICE
    $JBS
    Medical/Dental Instruments
    Health Care
    Investment Bankers/Brokers/Service
    Finance
    Get the next $GKOS alert in real time by email

    NEW YORK, June 25, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. 

    Kristen Scholer delivers the pre-market update on June 25th

    • Equities are little changed Wednesday morning after jumping by more than 1% on Tuesday. The DOW gained over 500 points while the S&P 500 sits just shy of a record high.
    • Driving those gains were easing tensions in the Middle East, resulting in crude oil prices falling by approximately 5% during Tuesday's session. President Trump announced a ceasefire agreement on Monday night.
    • Fed Chair Powell reiterated the Central Bank's wait-and-see approach to cutting interest rates in a testimony before the House Financial Services Committee on Tuesday. The Fed last cut rates in December.

    Opening Bell

    JBS N.V. (NYSE:JBS) celebrates its recent listing

    Closing Bell

    Glaukos Corporation (NYSE:GKOS) celebrates the 10th anniversary of its IPO

    Click here to download the NYSE TV App

    NYSE Logo (PRNewsfoto/New York Stock Exchange)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nyse-content-advisory-pre-market-update--sp-500-trades-within-1-of-record-302490894.html

    SOURCE New York Stock Exchange

    Get the next $GKOS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GKOS
    $ICE
    $JBS

    CompanyDatePrice TargetRatingAnalyst
    Intercontinental Exchange Inc.
    $ICE
    10/13/2025$210.00Outperform → Strong Buy
    Raymond James
    Glaukos Corporation
    $GKOS
    10/1/2025$103.00Buy
    Goldman
    JBS N.V.
    $JBS
    6/26/2025$20.00Outperform
    BMO Capital Markets
    JBS N.V.
    $JBS
    6/18/2025$21.00Buy
    BofA Securities
    Glaukos Corporation
    $GKOS
    5/1/2025$86.00Overweight → Equal Weight
    Wells Fargo
    Glaukos Corporation
    $GKOS
    2/19/2025$140.00 → $200.00Neutral → Outperform
    Mizuho
    Glaukos Corporation
    $GKOS
    12/11/2024$132.00 → $162.00Neutral → Buy
    Citigroup
    Glaukos Corporation
    $GKOS
    12/6/2024$182.00Buy
    UBS
    More analyst ratings

    $GKOS
    $ICE
    $JBS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Technology Officer Kapani Mayur exercised 5,345 shares at a strike of $57.31 and sold $1,601,862 worth of shares (10,082 units at $158.88), decreasing direct ownership by 7% to 65,240 units (SEC Form 4)

    4 - Intercontinental Exchange, Inc. (0001571949) (Issuer)

    10/10/25 4:30:10 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    PRESIDENT & COO Gilliam Joseph E covered exercise/tax liability with 1,056 shares, decreasing direct ownership by 0.94% to 111,706 units (SEC Form 4)

    4 - GLAUKOS Corp (0001192448) (Issuer)

    9/24/25 6:54:01 PM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    CHIEF DEVELOPMENT OFFICER Navratil Tomas sold $43,541 worth of shares (517 units at $84.22) and covered exercise/tax liability with 483 shares, decreasing direct ownership by 1% to 75,907 units (SEC Form 4)

    4 - GLAUKOS Corp (0001192448) (Issuer)

    9/24/25 6:53:20 PM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    $GKOS
    $ICE
    $JBS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    NYSE Content Advisory: Pre-Market Update + International Day kicks off

    NEW YORK, Oct. 23, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on October 23rd Stocks are little changed early Thursday after the major indices slid yesterday. Easing concerns about U.S.-China trade tensions, President Trump said Wednesday evening that his meeting with Xi Jinping is "scheduled."Markets moved lower in the previous session after Treasury Secretary Bessent said that the administration is considering curbing exports made with U.S. softw

    10/23/25 8:55:00 AM ET
    $ICE
    $NRGV
    Investment Bankers/Brokers/Service
    Finance
    Industrial Machinery/Components
    Miscellaneous

    NYSE Content Advisory: Pre-Market Update + Uniphore raises $260 million to boost AI leadership

    NEW YORK, Oct. 22, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on October 22nd Stocks are down Wednesday morning after the DOW closed at a record yesterday thanks to strong earnings from NYSE-listed firms Coca-Cola and 3M. The stocks jumped more than 4% and 7%, respectively.Uniphore has closed its $260 million Series F round, backed by tech giants including Nvidia, AMD, Databricks, and NYSE-listed Snowflake. The company said the funds will be used t

    10/22/25 8:55:00 AM ET
    $ICE
    $NOAH
    Investment Bankers/Brokers/Service
    Finance
    Investment Managers

    Open Interest across ICE's Global Futures and Options Markets Reaches a Record 107 Million Contracts

    Record Open Interest across Commodities, Energy, Oil, Brent and TTF Futures Intercontinental Exchange, Inc. (NYSE:ICE), a leading global provider of technology and data, today announced that its global futures and options markets reached record open interest (OI) of 107.6 million contracts on October 20, 2025, up 16% year-over-year (y/y). The records hit on October 20, 2025, include: Record total futures OI of 57.5 million, up 17% y/y. Record commodities futures OI of 43.2 million, up 14% y/y. Record energy futures OI of 41.1 million, up 14% y/y. Record oil futures OI of 11.2 million, up 24% y/y. Record ICE Brent futures OI of 3.1 million, up 27% y/y. Record European n

    10/22/25 7:30:00 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    $GKOS
    $ICE
    $JBS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for IDOSE TR issued to GLAUKOS CORP

    Submission status for GLAUKOS CORP's drug IDOSE TR (ORIG-1) with active ingredient TRAVOPROST has changed to 'Approval' on 12/13/2023. Application Category: NDA, Application Number: 218010, Application Classification: Type 3 - New Dosage Form

    12/15/23 11:41:09 AM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    FDA Approval for TRAVOPROST issued to GLAUKOS CORP

    Submission status for GLAUKOS CORP's drug TRAVOPROST (ORIG-1) with active ingredient TRAVOPROST has changed to 'Approval' on 12/13/2023. Application Category: NDA, Application Number: 218010, Application Classification: Type 3 - New Dosage Form

    12/14/23 7:41:03 AM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    $GKOS
    $ICE
    $JBS
    SEC Filings

    View All

    SEC Form 6-K filed by JBS N.V.

    6-K - JBS N.V. (0001791942) (Filer)

    10/14/25 6:30:01 AM ET
    $JBS
    Meat/Poultry/Fish
    Consumer Staples

    SEC Form 6-K filed by JBS N.V.

    6-K - JBS N.V. (0001791942) (Filer)

    10/8/25 6:35:36 PM ET
    $JBS
    Meat/Poultry/Fish
    Consumer Staples

    Intercontinental Exchange Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Intercontinental Exchange, Inc. (0001571949) (Filer)

    10/7/25 5:05:15 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    $GKOS
    $ICE
    $JBS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Intercontinental Exchange upgraded by Raymond James with a new price target

    Raymond James upgraded Intercontinental Exchange from Outperform to Strong Buy and set a new price target of $210.00

    10/13/25 8:40:25 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    Goldman initiated coverage on Glaukos with a new price target

    Goldman initiated coverage of Glaukos with a rating of Buy and set a new price target of $103.00

    10/1/25 8:52:09 AM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    BMO Capital Markets initiated coverage on JBS SA with a new price target

    BMO Capital Markets initiated coverage of JBS SA with a rating of Outperform and set a new price target of $20.00

    6/26/25 8:10:45 AM ET
    $JBS
    Meat/Poultry/Fish
    Consumer Staples

    $GKOS
    $ICE
    $JBS
    Leadership Updates

    Live Leadership Updates

    View All

    Lord Hill of Oareford Elected to Board of Directors of Intercontinental Exchange

    Intercontinental Exchange, Inc. (NYSE:ICE), a leading global provider of technology and data, today announced that its Board of Directors has elected The Rt. Hon. the Lord Hill of Oareford CBE (Lord Hill) as a new director, effective September 18, 2025. Lord Hill, who currently serves on the Board of Directors of ICE Endex Markets, a subsidiary of ICE, is also expected to join the Board of Directors of ICE Futures Europe subject to regulatory approval. "On behalf of the Board, I am pleased to welcome our colleague, Lord Hill, to his expanded role at ICE," said Jeffrey C. Sprecher, Founder, Chair and CEO of Intercontinental Exchange. "Lord Hill brings tremendous depth and breadth of experi

    9/18/25 4:15:00 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    NYSE Content Advisory: Pre-Market update + Fed Chair Jerome Powell Set to Deliver Jackson Hole Speech

    NEW YORK, Aug. 22, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on August 22nd Markets are closely watching the Fed's economic policy symposium in Jackson Hole, where Chair Jerome Powell will speak at 10 a.m. ET.Nearly 70% of traders expect a Fed rate cut in September amid dual concerns about inflation and employment highlighted in the Fed's July meeting minutes.The Fed's July meeting minutes emphasized policymakers' concerns about both inflation ris

    8/22/25 8:55:00 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    Mizuho Americas Joins ICE Clear Credit as Clearing Member

    Intercontinental Exchange, Inc. (NYSE:ICE), a leading global provider of technology and data, today announced that Mizuho Americas through its security-based swap dealer Mizuho Capital Markets LLC, part of Mizuho Financial Group (NYSE:MFG), has become a clearing member at ICE Clear Credit, the leading global clearinghouse for credit default swaps. "Mizuho Americas is excited to join ICE Clear Credit to enhance our product offering and approach to capital and risk management delivering efficiencies across our CDS portfolios," said Natalya Rasmussen, Chief Operating Officer, Fixed Income Division, Mizuho Americas. "The opportunity to centrally clear products is an important step forward for

    8/6/25 9:00:00 AM ET
    $ICE
    $MFG
    Investment Bankers/Brokers/Service
    Finance
    Major Banks

    $GKOS
    $ICE
    $JBS
    Financials

    Live finance-specific insights

    View All

    Glaukos Announces FDA Approval of Epioxa™

    Epioxa Provides the Ophthalmic Community and Patients with the First and Only FDA-Approved, Incision-Free, Topical Drug Therapy for Keratoconus Epioxa Represents a Novel, Groundbreaking Therapy for Patients Afflicted by This Sight-Threatening Rare Disease Epioxa Expected to Be Commercially Available in Q1 2026 Glaukos Corporation (NYSE:GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, announced today the U.S. Food and Drug Administration (FDA) approved its Epioxa™ HD / Epioxa™ ("Epioxa") New Drug Application (NDA). Epioxa is a groundbreaking advancement in corneal cross-

    10/20/25 7:00:00 AM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    AGNC Investment Corp. Announces Launch of Three Current Coupon Agency MBS Indices

    BETHESDA, Md., Oct. 15, 2025 /PRNewswire/ -- AGNC Investment Corp. (NASDAQ:AGNC) ("AGNC" or the "Company") announced today that AGNC and Intercontinental Exchange, Inc. ("ICE") have developed a series of fixed income indices that track the performance of current coupon Agency mortgage-backed securities ("MBS"): The AGNC ICE UMBS 30-Year Current Coupon Index (AGNCU30C), comprised of 30-year fixed rate residential mortgage-backed securities issued under the Uniform Mortgage-Backed Security ("UMBS") program guaranteed by Fannie Mae and/or Freddie MacThe AGNC ICE UMBS 15-Year Current Coupon Index (AGNCU15C), comprised of 15-year fixed rate residential mortgage-backed securities issued under the

    10/15/25 4:01:00 PM ET
    $AGNC
    $ICE
    Real Estate Investment Trusts
    Real Estate
    Investment Bankers/Brokers/Service
    Finance

    Glaukos to Release Third Quarter 2025 Financial Results after Market Close on October 29

    Conference Call and Webcast Scheduled for 1:30 p.m. PT Glaukos Corporation (NYSE:GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release third quarter 2025 financial results after the market close on Wednesday, October 29, 2025. The company's management will discuss the results during a conference call and simultaneous webcast at 1:30 p.m. PT (4:30 p.m. ET) on October 29, 2025. A link to the live webcast will be available on the company's website at http://investors.glaukos.com. To participate in the conference call, please dial 800-715-9871 (U.S.) or 646-307-196

    10/8/25 7:00:00 AM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    $GKOS
    $ICE
    $JBS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Glaukos Corporation

    SC 13G/A - GLAUKOS Corp (0001192448) (Subject)

    11/14/24 1:21:45 PM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Glaukos Corporation (Amendment)

    SC 13G/A - GLAUKOS Corp (0001192448) (Subject)

    2/14/24 3:55:55 PM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Glaukos Corporation (Amendment)

    SC 13G/A - GLAUKOS Corp (0001192448) (Subject)

    2/13/24 5:41:34 PM ET
    $GKOS
    Medical/Dental Instruments
    Health Care